Latest News Archive

Please select Category, Year, and then Month to display items

Study exposes the stark reality of drought resilience among smallholder livestock farmers

05 June 2023 | Story Leonie Bolleurs | Photo Supplied

Prof Bahta — For the past three years, Prof Yonas Bahta has studied the resilience of smallholder livestock farmers in agricultural drought, and the competitiveness of agri-food commodities.

The agricultural sector is marked by farmers’ daily struggles, including price hikes, climate change effects, and pest and disease outbreaks.

Prof Yonas T Bahta, Associate Professor and astute National Research Foundation (NRF) C2-rated researcher in the Department of Agricultural Economics at the University of the Free State (UFS), found that smallholder farmers who received drought relief support saw an improvement in their welfare. The study also found that economic capital, social capital, human capital, and natural capital substantially affected the welfare of smallholder farmers.

Agricultural drought

These findings came from the study, titled: The resilience of households to agricultural drought in the Northern Cape province of South Africa. Prof Bahta’s aim with this study was threefold – to assess household resilience to agricultural drought among smallholder livestock farmers, to evaluate the welfare of smallholder farming households affected by agricultural drought, and to identify factors influencing agricultural drought resilience and food insecurity among smallholder livestock farmers.

During his investigation, he found that only 9% of the smallholder livestock farmers were resilient to agricultural drought. According to him, farming households with access to credit, farmers who received assistance from the government (such as training and feed) during drought, and farmers who are part of a cooperative proved to be more resilient to agricultural drought.

When it comes to food security, he discovered that assets, social safety nets, and indicators of adaptive capacity had a positive influence on households' ability to withstand food insecurity. Alternatively, climate change indicators negatively impacted households’ resilience to food insecurity.

For the past three years, he has studied the resilience of smallholder livestock farmers in agricultural drought. He believes that resilience – the ability to bounce back from adversities – is crucial.

According to him, both the smallholder livestock sector (farmers) and the agrifood industry need to develop resilience to effectively cope with and recover from agricultural drought, macroeconomic stability (inflation), competitiveness, productivity, and other related factors.

Competitiveness of agri-food commodities

Prof Bahta also launched investigations into the competitiveness of agri-food commodities in South Africa as well as Namibia.

The studies were titled: Competitiveness of Namibia’s Agrifood Commodities: Implications for Food Security and Competitiveness of South Africa’s Agrifood Commodities.

In these studies, he respectively looked at the competitiveness of South Africa’s and Namibia’s agrifood products, the factors that influence it, and its implication for food security.

In both countries, he discovered a combination of comparative advantage and disadvantage.

“South Africa and Namibia exhibited a trade structure that was less concentrated and not dependant on international trade in the agri-food industry, having minimal impact on Namibia's food security. The productivity of agriculture and GDP per capita positively influenced the comparative advantage of South Africa, whereas land productivity and GDP per capita influenced the degree of food insecurity in Namibia,” explains Prof Bahta the main research findings.

Research outputs

The study on the resilience of smallholder livestock farmers was supported by funding from the National Research Foundation. To explore the competitiveness of agri-food commodities, Prof Bahta collaborated with the Namibia University of Science and Technology (NUST), benefiting from their strong existing academic relationship. The UFS Office for International Affairs played a key role in facilitating this study, with research partnerships existing between the universities of both countries.

According to Prof Bahta, the findings of these two studies have resulted in the publication of more than 13 articles in journals ranking in the highest (Q1) and second highest categories (Q2) in the specific field. A paper will also be presented at the upcoming International Food and Agribusiness Management Association (IFAMA) international conference in New Zealand from 17 to 20 June 2023.

Furthermore, five popular articles on the main findings of the studies (written in non-technical language) were also published on these topics, focusing on the farmers and policy makers (as a policy brief and popular) as the target audience. These articles looked at, among others, the impact of policy intervention on food insecurity in times of shock; coping strategies of smallholder livestock farmers during food insecurity shocks; measuring the resilience of female smallholders in South Africa; and farming for success.

This study also resulted in the graduation of three master's students (two with distinction) and three honours students.

Looking ahead, Prof Bahta emphasises the necessity for conducting similar studies targeting both commercial and smallholder farmers, focusing on crops and livestock in various provinces across South Africa. He also feels that connections need to be established with universities besides NUST.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease

2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013

The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.

In future further evaluation will be performed in other forms of hypocholesterolemia.

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept